Cargando…
Rotigotine protects against oxidized low-density lipoprotein(ox-LDL)-induced damages in human umbilical vein endothelial cells(HUVECs)
Rotigotine is a non-ergoline dopamine agonist that has been licensed for the treatment of Parkinson’s disease. Cardiovascular diseases are the world’s leading cause of death. Ox-LDL- induced endothelial damages are involved in the initiation and progression of cardiovascular diseases. In this study,...
Autores principales: | Kang, Hui, Yu, Hui, Fan, Jingxiu, Cao, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810014/ https://www.ncbi.nlm.nih.gov/pubmed/34860135 http://dx.doi.org/10.1080/21655979.2021.2000224 |
Ejemplares similares
-
Beneficial Effects of Ticagrelor on Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Apoptosis in Human Umbilical Vein Endothelial Cells
por: Kang, Meini, et al.
Publicado: (2019) -
Pinoresinol Diglucoside Alleviates oxLDL-Induced Dysfunction in Human Umbilical Vein Endothelial Cells
por: Yao, Jinpeng, et al.
Publicado: (2016) -
Platelet-rich Plasma Protects HUVECs against oX-LDL-induced Injury
por: Wang, Yang, et al.
Publicado: (2018) -
Protective Effect of the Silkworm Protein 30Kc6 on Human Vascular Endothelial Cells Damaged by Oxidized Low Density Lipoprotein (Ox-LDL)
por: Yu, Wei, et al.
Publicado: (2013) -
Ceramide Production Mediates Aldosterone-Induced Human Umbilical Vein Endothelial Cell (HUVEC) Damages
por: Zhang, Yumei, et al.
Publicado: (2016)